Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Fidaxomicin is a cutting-edge antibiotic developed by Optimer that specializes in refractory Clostridium infections and ushers a new chapter in anti-infective therapy by inhibiting···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：252
Fidaxomicinis an innovative macrolide antibiotic developed by Optimer, which has demonstrated excellent efficacy and safety by blocking bacterial RNA polymerase for the targeted tr···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：196
Fidaxomicin is a macrolide antibiotic from Optimer, which brings an efficient and safe treatment regimen for patients with refractory Clostridium infection with its unique RNA poly···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：263
Fidaxomicin is an innovative drug carefully developed by Optimer, specially designed for the treatment of refractory Clostridium infection, by blocking bacterial RNA polymerase, en···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：191
Fidaxomicin is an antibiotic developed by Optimer, which targets the unique mechanism of refractory Clostridium and can effectively inhibit RNA polymerase, ensuring clinically effi···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：206
Fidaxomicin is an innovative macrolide antibiotic developed by Optimer, which is designed for the treatment of refractory Clostridium infections with its unique RNA polymerase inhi···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：201
Fidaxomicinis an innovative antibiotic designed to treat diarrhea caused by Clostridium difficile by inhibiting bacterial growth through a unique mechanism that reduces interferenc···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：251
Fidaxomicin is an innovative antibiotic designed to treat diarrhea caused by Clostridium difficile by inhibiting bacterial growth through a unique mechanism that reduces interferen···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：211
Fidaxomicin is a new macrolide antibiotic used for the treatment of Clostridium difficile-associated diarrhea by inhibiting bacterial RNA polymerase and has little effect on the no···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：259
Stiripentol is a drug that reduces seizures by modulating GABA receptors, especially for patients with Dravet syndrome. It has demonstrated significant efficacy in clinical trials,···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：227
Stiripentol was approved by the FDA in 2018 for significantly improving seizure frequency and improving the quality of life of infants and young children suffering from Dravet synd···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：242
Patients with Dravet syndrome often find it difficult to control seizures with traditional drugs, and Stiripentol, as a new type of drug, has shown significant clinical effects by ···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：210
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3172024-09-07
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：112025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：232025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：272025-27-11
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended：3062025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended：2712025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended：3492024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended：2492024-24-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
